SOURCE: Plandai Biotechnology, Inc.

Plandai Biotechnology, Inc.

May 28, 2013 08:30 ET

Plandai Biotechnology, Inc.'s Tomato Based Product Offers Benefits for Certain Cancers

NEW YORK, NY--(Marketwired - May 28, 2013) - Plandaí Biotechnology, Inc.'s (OTCQB: PLPL) Phytofare™ brand will feature three botanical extracts with a much higher bioavailability than the current market offers. In a three-part series covering each of the new products, Stock Market Media Group, a full service research and content development investor relations firm, has covered the green tea based Phytofare™ Catechin Extract and the company's citrus based Phytofare™ Limonoid Glycoside Complex. 

In this third installment, Plandaí's tomato based Phytofare™ Carotenoid Extract will be highlighted.

Each of the three new products will be individually labeled and branded under the Phytofare™ name and these products will offer a much higher absorption rate to the company's customers. Phytofare™ Carotenoid Extract is produced from tomato and formulated in oleoresin containing lycopene and the opaque precursors phytoene and phytofluene in a highly concentrated, pure, stable and bioavailable form.

There have been more than 250 scientific studies conducted in the last 15 years and those studies have shown that carotenoids like lycopene have important health benefits for cardiovascular disease and certain cancers. The best results have been seen with breast, skin, prostate and colon cancers.

Prostate cancer, in particular, has received considerable attention with protective effects reported 19 times and one study that highlighted the benefit of processed tomato products over fresh tomatoes. The biggest limitation of using lycopene as a nutraceutical has been the poor bioavailability, stability, and rapid degradation to heat and light. 

Plandaí Biotechnology's proprietary technology will change that since, with its hydrodynamic sheering process, live plant-materials are converted at the molecular level during extraction into a nano-particle sized isomeric structure that resembles that found in human tissues.

Continue reading this article at www.stockmarketmediagroup.com/features.

About Stock Market Media Group

Stock Market Media Group, formerly Stock House Group, is a full service Investment Relations firm specializing in Research, Content Development and Awareness. The firm offers a platform for CEOs to tell their story through the media with its Feature Articles, Research Reports, and CEO Interviews. At the same time, the company is building a library of Research on its website for Investors to become better informed on small cap stocks. For more information, visit our website at www.stockmarketmediagroup.com.

Contact Information